GlassScriptPhysician profile
Silky K Bagga
NPI 1467788406
$2,809.36
in general payments reported to CMS, 2019-2025
29 companies · $178 in 2025
The $178 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $554 · 2020: $28.39 · 2021: $400 · 2022: $264 · 2023: $716 · 2024: $668 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,562.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $606.13 | 2021-2025 | Puraply, Affinity, Via Matrix |
| Smith+Nephew, INC. | $334.02 | 2019-2024 | Renasys Go V2 Home, Grafix, Oasis |
| Paratek Pharmaceuticals, INC. | $322.86 | 2021-2023 | Nuzyra |
| Kerecis Limited | $226.37 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Next Science LLC | $202.64 | 2023 | Blastx, Xperience, Surgx |
| Osiris Therapeutics INC. | $135.11 | 2019 | |
| Hydrofera LLC | $111.43 | 2024 | Hydrofera Blue |
| Allergan, INC. | $78.76 | 2019 | |
| Molnlycke Health Care US, LLC | $72.92 | 2024-2025 | Mepilex Border Flex, Exufiber, Mesalt |
| Keswick Pharmaceuticals LLC | $72.77 | 2019 | |
| Hartmann USA, INC. | $72.35 | 2024 | Zetuvit Plus 10x10 P10 |
| Abbvie INC. | $65.00 | 2021-2023 | Dalvance |
| Bsn Medical INC | $59.95 | 2022-2025 | |
| Aroa Biosurgery Incorporated | $54.20 | 2019-2020 | |
| Tactile Systems Technology INC | $53.28 | 2019-2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $49.07 | 2019 | |
| Ovik Health, LLC | $30.33 | 2022-2023 | |
| Misonix INC | $29.75 | 2019 | |
| Reddress USA, INC. | $28.90 | 2024 | |
| Nabriva Therapeutics, Plc | $26.76 | 2021 | |
| Solventum Corporation | $26.09 | 2024 | Activ.A.C. |
| Lifenet Health | $24.30 | 2025 | Theragenesis Wound Matrix |
| Abbott Laboratories | $23.67 | 2023 | Freestyle Libre 3 |
| Advanced Oxygen Therapy INC. | $22.89 | 2024 | Topical Oxygen Chamber For Extremities |
| Convatec INC. | $20.76 | 2022 | |
| Acell, INC. | $16.32 | 2019 | |
| Reprise Biomedical, INC. | $15.95 | 2024 | Miro3d |
| Kci USA, INC. | $13.46 | 2019 | |
| Urgo Medical North America, LLC | $13.32 | 2024 | Urgoclean Ag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Silky Bagga listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.